Zosano Pharma Corporation
Latest round
- Series C
Last raised
- Aug 2010
Total raised
- $115M
Investors
- 4
About Zosano Pharma Corporation
Founded in 2006, Zosano Pharma Corporation is based in Fremont, US, and specializes in advanced transdermal delivery systems. The firm has completed 12 deals to date, with the latest deal being an ADD-ON Trade Sale.Zosano Pharma Corporation develops transdermal delivery systems aimed at improving patient outcomes by providing controlled release of medications. Their primary focus is on pain management therapies, utilizing their proprietary technology to enhance the bioavailability and patient compliance of drugs.In the most recent fiscal year of 2021, Zosano Pharma Corporation reported a revenue of USD 785,000 and an EBITDA of USD -29,781,000. The company plans to expand into new markets in Europe and Asia-Pacific by 2025, utilizing its advanced transdermal delivery technology to meet local healthcare needs.
Who invested in Zosano Pharma Corporation
4 investors across 4 rounds
See all investors in Zosano Pharma Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zosano Pharma Corporation
Who invested in Zosano Pharma Corporation?
Zosano Pharma Corporation has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zosano Pharma Corporation raised?
Zosano Pharma Corporation has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Zosano Pharma Corporation last raise money?
Zosano Pharma Corporation's most recent round on record is a Series C, in Aug 2010.
What does Zosano Pharma Corporation do?
Founded in 2006, Zosano Pharma Corporation is based in Fremont, US, and specializes in advanced transdermal delivery systems.
Where is Zosano Pharma Corporation headquartered?
Zosano Pharma Corporation is headquartered in Fremont, US.
Which VCs invest in companies like Zosano Pharma Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zosano Pharma Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Zosano Pharma Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.